- Home
- RTACW vs LFMDP Comparison
RTACW vs LFMDP Comparison
Compare RTACW & LFMDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | RTACW | LFMDP |
|---|---|---|
| Founded | N/A | N/A |
| Country | United States | United States |
| Employees | N/A | 384 |
| Industry | Blank Checks | Medical/Nursing Services |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | 2025 | N/A |
Fundamental Metrics
Financial Performance| Metric | RTACW | LFMDP |
|---|---|---|
| Price | $0.85 | $23.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 41.1K | 2.1K |
| Earning Date | N/A | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.41 | $18.50 |
| 52 Week High | $2.52 | $24.75 |
Technical Indicators
Market Signals| Indicator | RTACW | LFMDP |
|---|---|---|
| Relative Strength Index (RSI) | 55.65 | 47.40 |
| Support Level | $0.78 | $23.48 |
| Resistance Level | $1.00 | $24.05 |
| Average True Range (ATR) | 0.08 | 0.21 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 62.02 | 17.86 |
Price Performance
Historical ComparisonAbout RTACW Renatus Tactical Acquisition Corp I Warrant
Renatus Tactical Acquisition Corp I is a blank check company.
About LFMDP LifeMD Inc.
LifeMD Inc is a patient-centric, direct-to-patient healthcare company providing a high-quality, cost-effective, and convenient way for patients to access virtual medical care and pharmacy services. The Company's portfolio of brands within continuing operations is now managed as a single operating segment, Telehealth. Telehealth platform integrates core capabilities, includes: A nationwide pharmacy network, A wholly-owned commercial pharmacy, A fully integrated patient care center, A direct-to-patient marketing infrastructure for acquisition and retention, and AI-enabled clinical and operational technologies.